TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT00000672 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05168748 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05168748 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT06733233 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06733233 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05529615 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05948761 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05948761 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05608616 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06753331 — Predictive Biomarker (PRD): DSP mRNA
Genes: DSP
Study NCT06429813 — Predictive Biomarker (PRD): ARSI mRNA
Genes: ARSI
Study NCT06259617 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06243393 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06243393 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05444556 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT05444556 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT06753084 — Predictive Biomarker (PRD); Safety Biomarker (SAF): FGG mRNA
Genes: FGG; PRO2061
Study NCT06064630 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05017883 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04953325 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04982354 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04982354 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06174792 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT06174792 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT04777617 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05229068 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06417840 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06417840 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT04936607 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT04853758 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05569434 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05904665 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT05904665 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05904665 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT06270082 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT05655910 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05655910 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05655910 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06565026 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06298084 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT06298084 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04732494 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT06110754 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05406830 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT05999097 — Predictive Biomarker (PRD): FOS mRNA
Genes: FOS; G0S7
Study NCT06429150 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06429150 — Predictive Biomarker (PRD): GPRC5D mRNA
Genes: GPRC5D
Study NCT03787082 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT05180188 — Predictive Biomarker (PRD): TTN mRNA
Genes: TTN
Study NCT05565378 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04959266 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04991870 — Predictive Biomarker (PRD): NR3C1 mRNA
Genes: NR3C1; GRL
Study NCT04952597 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT05696483 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT05614258 — Predictive Biomarker (PRD): TNFRSF9 mRNA
Genes: TNFRSF9; CD137; ILA
Study NCT05193916 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT05358106 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05423665 — Predictive Biomarker (PRD): FGR mRNA
Genes: FGR; SRC2
Study NCT05423665 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04749901 — Predictive Biomarker (PRD): PTS mRNA
Genes: PTS
Study NCT06304103 — Predictive Biomarker (PRD): LTB mRNA
Genes: LTB; TNFC; TNFSF3
Study NCT05095636 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05233865 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05582720 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05582720 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05483634 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05976516 — Predictive Biomarker (PRD): CXCL2 mRNA
Genes: CXCL2; GRO2; GROB; MIP2A; SCYB2
Study NCT05976516 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04448834 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06490107 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT05218148 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06045403 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05283109 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05007938 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05028348 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study NCT04818333 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06068881 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT06358573 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT05517109 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05507476 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06382103 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06106581 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06554847 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT03886506 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05668962 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT05951894 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study NCT05951894 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT05951894 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05430360 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT05430360 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06327308 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06342661 — Predictive Biomarker (PRD): VSIR mRNA
Genes: VSIR; C10orf54; SISP1; VISTA; PP2135; UNQ730/PRO1412
Study NCT06342661 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06342661 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT05915507 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT05915507 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT05915507 — Safety Biomarker (SAF): Interleukin 1
Study NCT05915507 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04689659 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT04530890 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT04530890 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT05323396 — Safety Biomarker (SAF): Hemoglobin scavenger receptor
Genes: CD163; M130
Study NCT05323396 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study NCT05235126 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06480240 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study NCT04262323 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05867004 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05680038 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05972031 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03867487 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04956172 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT04252768 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04252768 — Predictive Biomarker (PRD): Hormone receptor
Study NCT05181501 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05533294 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT04469101 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04973527 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05786430 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04706065 — Predictive Biomarker (PRD): SHMT1 mRNA
Genes: SHMT1
Study NCT05696665 — Pharmacodynamic Biomarker (PDY): Synuclein alpha
Genes: SNCA; NACP; PARK1
Study NCT05117658 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT06518382 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05607004 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05607004 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT06663280 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05284162 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05103293 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05071196 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05232994 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06668558 — Predictive Biomarker (PRD): ELN mRNA
Genes: ELN
Study NCT02014428 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06706492 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04988620 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06621459 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06621459 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05931601 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06622798 — Predictive Biomarker (PRD): GSS mRNA
Genes: GSS
Study NCT04990479 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06564974 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT05534347 — Safety Biomarker (SAF): Cellular communication network factor 1
Genes: CCN1; CYR61; GIG1; IGFBP10
Study NCT04920838 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04839510 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06650436 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PSD mRNA
Genes: PSD; EFA6; EFA6A; KIAA2011; PSD1; TYL
Study NCT06282432 — Predictive Biomarker (PRD): LAD1 mRNA
Genes: LAD1; LAD
Study NCT06282432 — Predictive Biomarker (PRD): ITGB2 mRNA
Genes: ITGB2; CD18; MFI7
Study NCT06058572 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT05244044 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study NCT04417803 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05263739 — Predictive Biomarker (PRD): TNFRSF13C mRNA
Genes: TNFRSF13C; BAFFR; BR3
Study NCT06260410 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05681650 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06254001 — Surrogate Endpoint (SUR): Exhaled carbon monoxide
Study NCT05609201 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT05344729 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT03909893 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT04756765 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study NCT05272384 — Safety Biomarker (SAF): CDA
Genes: CDD
Study NCT04936126 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04936126 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT04936126 — Safety Biomarker (SAF): BDNF
Study NCT06200558 — Predictive Biomarker (PRD): ARSI mRNA
Genes: ARSI
Study NCT06200558 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06200558 — Predictive Biomarker (PRD): PC mRNA
Genes: PC
Study NCT06107608 — Predictive Biomarker (PRD): FAP mRNA
Genes: FAP
Study NCT05251714 — Predictive Biomarker (PRD): CFI mRNA
Genes: CFI; IF
Study NCT05251714 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05251714 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04581109 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04581109 — Predictive Biomarker (PRD): PTPRC mRNA
Genes: PTPRC; CD45
Study NCT05448417 — Pharmacodynamic Biomarker (PDY): High-frequency oscillations
Study NCT05351879 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT04991532 — Predictive Biomarker (PRD): KLRC2 mRNA
Genes: KLRC2; NKG2C
Study NCT05562882 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study NCT05257772 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06087341 — Predictive Biomarker (PRD): KLRK1 mRNA
Genes: KLRK1; D12S2489E; NKG2D
Study NCT05292781 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05292781 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study NCT05672654 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05672654 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT03679247 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06723964 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05323201 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT06305286 — Predictive Biomarker (PRD): CD40 mRNA
Genes: CD40; TNFRSF5
Study NCT06545838 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT06545838 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT05817448 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT05848518 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study NCT05848518 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06580314 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT06022276 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05485467 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06156618 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05308875 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05308875 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05308875 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study NCT05175638 — Predictive Biomarker (PRD): MIF mRNA
Genes: MIF; GLIF; MMIF
Study NCT06520488 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00671866 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study NCT06367673 — Predictive Biomarker (PRD): Myeloid cell surface antigen CD33
Genes: CD33; SIGLEC3
Study NCT05514496 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05514496 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05603793 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04888507 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT04888507 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT04986163 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06385431 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05920798 — Predictive Biomarker (PRD): Folate receptor alpha
Genes: FOLR1; FOLR
Study NCT04270201 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study NCT05600920 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06560931 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06065969 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04989413 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT06056687 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05769465 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT04715568 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04840641 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT04840641 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT04840641 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04840641 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT04840641 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT04840641 — Predictive Biomarker (PRD): NR1I2
Genes: ONR1; PXR; BXR; SXR; PAR2
Study NCT06466369 — Predictive Biomarker (PRD): PDE5A mRNA
Genes: PDE5A; PDE5
Study NCT06407375 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04737460 — Predictive Biomarker (PRD): MFSD8 mRNA
Genes: MFSD8; CLN7
Study NCT05629260 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04960527 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT04960527 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04960527 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06222632 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06222632 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06222632 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05256589 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06351566 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05874154 — Predictive Biomarker (PRD): GAST mRNA
Genes: GAST; GAS
Study NCT06330246 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT04629209 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04776980 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT04776980 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05269914 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05656417 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT05185531 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT06125834 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06125834 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT04672369 — Predictive Biomarker (PRD): TIGIT mRNA
Genes: TIGIT; VSIG9; VSTM3
Study NCT04950504 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study NCT05605678 — Predictive Biomarker (PRD): ABR mRNA
Genes: ABR
Study NCT05064878 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study NCT06132451 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06247995 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06247995 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06247995 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05586581 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study NCT06098456 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06098456 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT05387941 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06069674 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT05469750 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06044974 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06178393 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study NCT06391060 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT06705686 — Predictive Biomarker (PRD): TNK2 mRNA
Genes: TNK2; ACK1
Study NCT06705686 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT06705686 — Predictive Biomarker (PRD): LCK mRNA
Genes: LCK
Study NCT04433273 — Pharmacodynamic Biomarker (PDY): 5'-AMP-activated protein kinase subunit beta-1
Genes: PRKAB1; AMPK
Study NCT06111963 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT06381934 — Surrogate Endpoint (SUR): Serum sodium
Study NCT06183957 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04310423 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04310423 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04620772 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05236478 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05311891 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04805632 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06044350 — Predictive Biomarker (PRD): AQP4 mRNA
Genes: AQP4
Study NCT06566742 — Predictive Biomarker (PRD): IDH1 mRNA
Genes: IDH1; PICD
Study NCT01555723 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05300360 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1